Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 25030555)

1.

Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis C.

Miyoshi K, Ikebuchi Y, Ishida C, Okamoto K, Murawaki Y.

Intern Med. 2014;53(14):1461-8. Epub 2014 Jul 15.

2.
3.

Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.

Kovalenko E, Tacke F, Gressner OA, Zimmermann HW, Lahme B, Janetzko A, Wiederholt T, Berg T, Müller T, Trautwein C, Gressner AM, Weiskirchen R.

J Viral Hepat. 2009 Sep;16(9):612-20. doi: 10.1111/j.1365-2893.2009.01110.x. Epub 2009 Feb 20.

PMID:
19243500
4.

The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.

Okamoto K, Ishida C, Ikebuchi Y, Mandai M, Mimura K, Murawaki Y, Yuasa I.

Intern Med. 2010;49(10):887-95. Epub 2010 May 14.

5.

IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.

Zekri AR, Salama H, Medhat E, Bahnassy AA, Morsy HM, Lotfy MM, Ahmed R, Darwish T, Marei MS.

Asian Pac J Cancer Prev. 2014;15(17):7213-8.

6.

Association of TIMP-1 and TIMP-2 gene polymorphisms with progression of liver fibrosis in patients with type C chronic liver disease.

Ikebuchi Y, Ishida C, Okamoto K, Murawaki Y.

Biochem Genet. 2013 Aug;51(7-8):564-74. doi: 10.1007/s10528-013-9587-8. Epub 2013 Apr 7.

PMID:
23563628
7.

Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.

Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM.

Clin Chim Acta. 2002 Feb;316(1-2):83-94.

PMID:
11750277
8.

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes.

Bochud PY, Bibert S, Kutalik Z, Patin E, Guergnon J, Nalpas B, Goossens N, Kuske L, Müllhaupt B, Gerlach T, Heim MH, Moradpour D, Cerny A, Malinverni R, Regenass S, Dollenmaier G, Hirsch H, Martinetti G, Gorgiewski M, Bourlière M, Poynard T, Theodorou I, Abel L, Pol S, Dufour JF, Negro F; Swiss Hepatitis C Cohort Study Group; ANRS HC EP 26 Genoscan Study Group.

Hepatology. 2012 Feb;55(2):384-94. doi: 10.1002/hep.24678. Epub 2011 Dec 16.

PMID:
22180014
9.

Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.

Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Bottelli R, Mondelli MU, Civardi E, Silini EM.

Hepatology. 2002 Jul;36(1):195-201.

PMID:
12085365
10.

Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.

El-Bassiouni NE, Nosseir MM, Madkour ME, Zoheiry MM, Bekheit IW, Ibrahim RA, Ibrahim IM, El Bassiouny AE.

Mol Biol Rep. 2012 Jun;39(6):6843-50. doi: 10.1007/s11033-012-1509-z. Epub 2012 Feb 9.

PMID:
22318548
11.

The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.

Nischalke HD, Coenen M, Berger C, Aldenhoff K, Müller T, Berg T, Krämer B, Körner C, Odenthal M, Schulze F, Grünhage F, Nattermann J, Sauerbruch T, Spengler U.

Int J Cancer. 2012 Mar 15;130(6):1470-5. doi: 10.1002/ijc.26143. Epub 2011 Jun 18.

PMID:
21500195
12.

Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.

Gressner OA, Fang M, Li H, Lu LG, Gressner AM, Gao CF.

Clin Chim Acta. 2013 Jun 5;421:126-31. doi: 10.1016/j.cca.2013.02.029. Epub 2013 Mar 15.

PMID:
23501329
13.

CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.

Silvestri L, Sonzogni L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Leveri M, Cividini A, Mondelli MU, Civardi E, Silini EM.

Int J Cancer. 2003 Apr 10;104(3):310-7.

PMID:
12569554
14.
15.

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.

Fabris C, Falleti E, Cussigh A, Bitetto D, Fontanini E, Bignulin S, Cmet S, Fornasiere E, Fumolo E, Fangazio S, Cerutti A, Minisini R, Pirisi M, Toniutto P.

J Hepatol. 2011 Apr;54(4):716-22. doi: 10.1016/j.jhep.2010.07.019. Epub 2010 Sep 19.

PMID:
21146242
16.

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience.

Cho EJ, Jeong SH, Han BH, Lee SU, Yun BC, Park ET.

Clin Mol Hepatol. 2012 Jun;18(2):219-24. doi: 10.3350/cmh.2012.18.2.219. Epub 2012 Jun 26.

17.

Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4.

Rizk NM, Derbala MF.

Clin Res Hepatol Gastroenterol. 2013 Jun;37(3):262-8. doi: 10.1016/j.clinre.2012.09.012. Epub 2012 Nov 6.

PMID:
23137758
18.

Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.

Zekri Ael-R, Nassar AA, El-Din El-Rouby MN, Shousha HI, Barakat AB, El-Desouky ED, Zayed NA, Ahmed OS, El-Din Youssef AS, Kaseb AO, Abd El-Aziz AO, Bahnassy AA.

Asian Pac J Cancer Prev. 2014 Jan;14(11):6721-6.

19.

Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection.

Ydreborg M, Westin J, Rembeck K, Lindh M, Norrgren H, Holmberg A, Wejstål R, Norkrans G, Cardell K, Weiland O, Lagging M.

PLoS One. 2013 Nov 14;8(11):e80172. doi: 10.1371/journal.pone.0080172. eCollection 2013.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk